BE499168A - - Google Patents
Info
- Publication number
- BE499168A BE499168A BE499168DA BE499168A BE 499168 A BE499168 A BE 499168A BE 499168D A BE499168D A BE 499168DA BE 499168 A BE499168 A BE 499168A
- Authority
- BE
- Belgium
- Prior art keywords
- sep
- penicillin
- salt
- reacted
- amino
- Prior art date
Links
- 229960000626 benzylpenicillin Drugs 0.000 claims description 71
- 229940049954 Penicillin Drugs 0.000 claims description 57
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 56
- 239000011780 sodium chloride Substances 0.000 claims description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 37
- -1 tertiary amine salt Chemical class 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 6
- 230000000875 corresponding Effects 0.000 claims description 6
- 150000002960 penicillins Chemical class 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 229960004919 procaine Drugs 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 150000001447 alkali salts Chemical class 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 230000001747 exhibiting Effects 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 181
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 235000019371 penicillin G benzathine Nutrition 0.000 description 14
- 159000000000 sodium salts Chemical class 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 238000001914 filtration Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 210000004072 Lung Anatomy 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 210000004369 Blood Anatomy 0.000 description 9
- NLKNQRATVPKPDG-UHFFFAOYSA-M Potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000004185 Liver Anatomy 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 229940076185 Staphylococcus aureus Drugs 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 230000001476 alcoholic Effects 0.000 description 5
- WHRVRSCEWKLAHX-LQDWTQKMSA-N benzylpenicillin procaine Chemical compound [H+].CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 WHRVRSCEWKLAHX-LQDWTQKMSA-N 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000001264 neutralization Effects 0.000 description 5
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-N,N-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M Sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 210000000952 Spleen Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- PGMYKACGEOXYJE-UHFFFAOYSA-N Amyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N DMA Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000003802 Sputum Anatomy 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229940072049 amyl acetate Drugs 0.000 description 2
- 230000000844 anti-bacterial Effects 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 238000010908 decantation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- ASORWHHJEKMHSZ-UHFFFAOYSA-N iodomethanolate Chemical compound [O-]CI ASORWHHJEKMHSZ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organs Anatomy 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000002035 prolonged Effects 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- YMKBSXVBAHEQHF-UHFFFAOYSA-N (2-chloro-2-methylpropyl)benzene Chemical compound CC(C)(Cl)CC1=CC=CC=C1 YMKBSXVBAHEQHF-UHFFFAOYSA-N 0.000 description 1
- WNRWEBKEQARBKV-UHFFFAOYSA-N 1-(2-chloroethyl)piperidine Chemical compound ClCCN1CCCCC1 WNRWEBKEQARBKV-UHFFFAOYSA-N 0.000 description 1
- KZTWONRVIPPDKH-UHFFFAOYSA-N 2-(piperidin-1-yl)ethanol Chemical compound OCCN1CCCCC1 KZTWONRVIPPDKH-UHFFFAOYSA-N 0.000 description 1
- GYXWNSDLDXGMGU-UHFFFAOYSA-N 2-chloro-N,N-dimethylpropan-1-amine Chemical compound CC(Cl)CN(C)C GYXWNSDLDXGMGU-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N Acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 206010006451 Bronchitis Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- DOQCEYJPJXHWKF-UHFFFAOYSA-N CCC(N)(CCl)CC1=CC=CC=C1 Chemical compound CCC(N)(CCl)CC1=CC=CC=C1 DOQCEYJPJXHWKF-UHFFFAOYSA-N 0.000 description 1
- 208000007451 Chronic Bronchitis Diseases 0.000 description 1
- 229960002887 Deanol Drugs 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N Diethylethanolamine Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- WFKAJVHLWXSISD-UHFFFAOYSA-N Isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 1
- 206010061229 Lung infection Diseases 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- OLPIVHQXWIKOMC-UHFFFAOYSA-N N-(2-chloroethyl)-2-phenylethanamine Chemical compound ClCCNCCC1=CC=CC=C1 OLPIVHQXWIKOMC-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- 229960001309 Procaine hydrochloride Drugs 0.000 description 1
- 241001208007 Procas Species 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-M Sodium 2-anthraquinonesulfonate Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)[O-])=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-M 0.000 description 1
- 229940083599 Sodium Iodide Drugs 0.000 description 1
- ZCHPKWUIAASXPV-UHFFFAOYSA-N acetic acid;methanol Chemical compound OC.CC(O)=O ZCHPKWUIAASXPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 229940027983 antiseptics and disinfectants Quaternary ammonium compounds Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000002685 pulmonary Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE499168A true BE499168A (de) |
Family
ID=141639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE499168D BE499168A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE499168A (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2754297A (en) * | 1953-03-16 | 1956-07-10 | Olin Mathieson | Preparation of aminoalkyl-esters of penicillin |
| DE1014114B (de) * | 1952-02-29 | 1957-08-22 | Leo Pharm Prod Ltd | Verfahren zur Herstellung von Estern des Penicillins |
-
0
- BE BE499168D patent/BE499168A/fr unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1014114B (de) * | 1952-02-29 | 1957-08-22 | Leo Pharm Prod Ltd | Verfahren zur Herstellung von Estern des Penicillins |
| US2754297A (en) * | 1953-03-16 | 1956-07-10 | Olin Mathieson | Preparation of aminoalkyl-esters of penicillin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0033255B1 (de) | Oxim-Derivate von Erythromycin A, ihre Herstellung, ihre Verwendung als Pharmazeutika und sie enthaltende pharmazeutische Zusammensetzungen | |
| LU82387A1 (fr) | Esters d'acyl-carnitines,leur procede de preparation et compositions pharmaceutiques contenant ces esters | |
| FR2550788A1 (fr) | Nouveau procede de preparation d'a-6-desoxytetracyclines | |
| EP0001024A1 (de) | Kristallinische Form des Natriumsalzes von 7-Aminothiazolylacetamidocephalosporansäure, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Präparate | |
| CA2071983C (fr) | Derive de la beta-phenylisoserine, sa preparation et son emploi | |
| CA1095047A (fr) | Procede de preparation de nouveaux derives du 1,4- benzodioxane | |
| CA1037038A (fr) | Procede d'obtention de nouvelles urees tricycliques | |
| BE499168A (de) | ||
| BE1000625A3 (fr) | Sels d'acide (3s(z)) -2 (((1-(2-amino-4-thiazolyl)-2- ((2,2-dimethyl-4-oxo-1- (sulfooxy) -3-azetidinyl) amino) -2-oxoethylidene) amino) oxo) acetique, leur preparation et leur utilisation. | |
| CH629821A5 (fr) | Derives semi-synthetiques de l'oleandomycine et leur procede de preparation. | |
| CA1093582A (fr) | Procede d'obtention de nouvelles propylenediamines | |
| WO1996027593A1 (fr) | Analogues de l'arginine ayant une activite en tant qu'inhibiteurs de la no synthase | |
| BE528076A (de) | ||
| WO1998039286A1 (fr) | PROCEDE D'OBTENTION D'ENANTIOMERES D'ACIDES α-AMINES ET SELS DIASTEREOISOMERIQUES INTERMEDIAIRES | |
| CH645901A5 (fr) | Sel sesqui-sodique d'un diacide d'oxa-beta-lactame antibiotique. | |
| FR2496655A1 (fr) | Thiocarnitines, procede pour leur preparation et leur utilisation therapeutique, notamment dans le traitement des intoxications et des troubles de la fonction hepatique, le traitement des brulures et des maladies de l'epithelium | |
| BE505352A (de) | ||
| BE521451A (de) | ||
| BE636675A (de) | ||
| BE477049A (de) | ||
| CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
| BE622344A (de) | ||
| BE636257A (de) | ||
| BE567434A (de) | ||
| BE546149A (de) |